提高驾驶效率:在505 (b) 条例行动中利用基于模型的方法
Vishnu Dutt Sharma1, Venkatesh Atul Bhattaram1, Kevin Krudys2
1Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Journal of clinical pharmacology
|August 9, 2024
概括
505 (b) (2) 途径通过利用现有数据来简化药物批准. 基于模型的药物开发进一步加快了这一过程,通过使用定量模型来支持监管决策和证据生成.
科学领域:
- 制药科学 制药科学
- 监管科学 监管科学
- 药物开发 药物开发
背景情况:
- 1984年的哈奇-瓦克斯曼修正案建立了505申请途径.
- 这一途径允许FDA通过引用先前的研究来批准新药,避免重复测试.
- 与传统方法相比,它为药物批准提供了更有效和更快速的途径.
研究的目的:
- 讨论在505 (b) (ii) 监管框架内应用基于模型的药物开发 (MIDD).
- 突出数量模型如何提高505 (b) 提交的效率和有效性.
- 证明MIDD在支持新药应用的监管决策方面的价值.
主要方法:
- 审查了MIDD方法用于支持505 (b) (2) 提交的案例研究.
- 使用定量模型,包括人口药理动力学和暴露-反应模型.
- 将生理学,疾病和药理学知识整合到建模中.
主要成果:
- 在505个应用中,MIDD方法提供了有效性的证据.
- 模型为特定患者子组指导剂量建议,例如肝脏或功能障碍患者.
- 定量建模为监管政策和决策过程提供了信息.
结论:
- 基于模型的药物开发有助于通过505 (b) (2) 途径加快新药的批准.
- 量化模型的战略性使用加强了有效性的证据,并支持了监管行动.
- MIDD是优化药物开发和监管决策的宝贵工具,在505(b) ((2) 提交的背景下.
相关概念视频
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
47
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
47
Typical Model Studies
352
Fluid mechanics model studies often utilize scaled-down systems to predict fluid behavior in full-scale environments, such as river flows, dam spillways, and structures interacting with open surfaces. Maintaining Froude number similarity in river models is crucial, as it replicates surface flow features like wave patterns and velocities.
352
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Mechanistic Models: Overview of Compartment Models
76
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
76
Drug Control Governance: Regulatory Bodies and Their Impact
148
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
148
Methods of Documentation VI: Case Management Model
564
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
564


